Fusion Antibodies plc (FAB.L)

GBp 6.55

(0.77%)

Net Income Summary of Fusion Antibodies plc

Fusion Antibodies plc's latest annual net income in 2023 was -2.22 Million GBP , up 14.25% from previous year.
Fusion Antibodies plc's latest quarterly net income in 2023 FY was -2.22 Million GBP , up 14.25% from previous quarter.
Fusion Antibodies plc reported an annual net income of -2.59 Million GBP in 2022, down -116.33% from previous year.
Fusion Antibodies plc reported an annual net income of -1.2 Million GBP in 2021, up 58.61% from previous year.
Fusion Antibodies plc reported a quarterly net income of -1.35 Million GBP for 2023 Q2, down 0.0% from previous quarter.
Fusion Antibodies plc reported a quarterly net income of -869 Thousand GBP for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Fusion Antibodies plc (2023 - 2012)

Historical Annual Net Income of Fusion Antibodies plc (2023 - 2012)

Year	Net Income	Net Income Growth
2023	-2.22 Million GBP	14.25%
2022	-2.59 Million GBP	-116.33%
2021	-1.2 Million GBP	58.61%
2020	-2.89 Million GBP	-315.93%
2019	-697 Thousand GBP	44.87%
2018	-1.26 Million GBP	-80.64%
2017	-699.94 Thousand GBP	-683.51%
2016	119.95 Thousand GBP	-89.61%
2015	1.15 Million GBP	1455.97%
2014	-85.11 Thousand GBP	25.04%
2013	-113.53 Thousand GBP	75.78%
2012	-468.73 Thousand GBP	0.0%

Year	Net Income	Net Income Growth
2023 FY	-2.22 Million GBP	14.25%
2023 Q2	-1.35 Million GBP	0.0%
2023 Q4	-869 Thousand GBP	0.0%
2022 Q4	-1.48 Million GBP	0.0%
2022 FY	-2.59 Million GBP	-116.33%
2022 Q2	-1.11 Million GBP	0.0%
2021 FY	-1.2 Million GBP	58.61%
2021 Q4	-616 Thousand GBP	0.0%
2021 Q2	-584 Thousand GBP	0.0%
2020 Q2	-471 Thousand GBP	0.0%
2020 Q4	-2.42 Million GBP	0.0%
2020 FY	-2.89 Million GBP	-315.93%
2019 Q4	-224 Thousand GBP	0.0%
2019 Q2	-473 Thousand GBP	0.0%
2019 FY	-697 Thousand GBP	44.87%
2018 FY	-1.26 Million GBP	-80.64%
2018 Q4	-522 Thousand GBP	-65.14%
2018 Q3	-316.09 Thousand GBP	57.4%
2018 Q2	-742 Thousand GBP	-324.04%
2018 Q1	-174.98 Thousand GBP	67.2%
2017 Q2	-166.38 Thousand GBP	-654.82%
2017 Q4	-533.56 Thousand GBP	0.0%
2017 FY	-699.94 Thousand GBP	-683.51%
2017 Q1	29.98 Thousand GBP	0.0%
2016 Q1	288.52 Thousand GBP	0.0%
2016 FY	119.95 Thousand GBP	-89.61%
2016 Q4	29.98 Thousand GBP	0.0%
2016 Q3	29.98 Thousand GBP	0.0%
2015 Q4	288.52 Thousand GBP	0.0%
2015 Q3	288.52 Thousand GBP	1455.97%
2015 FY	1.15 Million GBP	1455.97%
2015 Q2	-21.27 Thousand GBP	0.0%
2015 Q1	-21.27 Thousand GBP	0.0%
2014 Q4	-21.27 Thousand GBP	0.0%
2014 Q3	-21.27 Thousand GBP	0.0%
2014 FY	-85.11 Thousand GBP	25.04%
2013 FY	-113.53 Thousand GBP	75.78%
2012 FY	-468.73 Thousand GBP	0.0%

Peer Net Income Comparison of Fusion Antibodies plc

Name	Net Income	Net Income Difference